Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome c oxidase subunit 6B1 pseudogene 2 (COX6B1P2) is a processed pseudogene that is genetically similar to the functional COX6B1 gene, which encodes one of the nuclear-encoded subunits of cytochrome c oxidase (Complex IV of the mitochondrial respiratory chain)[1][2]. COX6B1P2 emerged from a duplication and retrotransposition event and has acquired disabling mutations, preventing it from encoding a functional protein[1][2]. Like other pseudogenes, COX6B1P2 is considered nonfunctional and is not implicated directly in cellular metabolism, signaling, or disease phenotypes. Pseudogenes in general may be transcribed at low levels and can sometimes confer subtle regulatory effects, but no data support a functional role for COX6B1P2. Importantly, it can confound nucleic acid-based assays due to sequence similarity with its parent gene[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome c oxidase subunit 6B1 pseudogene 2 (COX6B1P2).